N-Acetyl Selank Amidate N-Acetyl Selank Amidate is a chemically modified analog of Selank, a synthetic heptapeptide developed in Russia. Selank itself mimics the sequence of tuftsin (a natural immunomodulatory tetrapeptide) extended with a proline-glycine-proline (Pro-Gly-Pro) motif. The “N-Acetyl” modification adds an acetyl group to the N-terminus, improving stability, bioavailability, and resistance to enzymatic degradation. The “Amidate” refers to amidation of the C-terminus, further enhancing lipophilicity and blood-brain barrier penetration. Chemical Structure: Selank base: Thr-Lys-Pro-Arg-Pro-Gly-Pro (sequence: TKPRPGP) N-Acetyl Selank Amidate: Ac-Thr-Lys-Pro-Arg-Pro-Gly-Pro-NH₂ This version is popular in nootropic and research chemical communities for purported cognitive and anxiolytic effects. Background and Development Origin: Selank was created at the Institute of Genetics and Selection of Industrial Microorganisms (Moscow) in the 1990s as a non-addictive alternative to benzodiazepines. It’s approved in Russia as a nasal spray (Selank®) for anxiety, generalized anxiety disorder (GAD), and neurasthenia. Modifications: The N-acetyl and amidate forms are not officially approved pharmaceuticals but are synthesized for research. They aim to optimize pharmacokinetics—e.g., longer half-life (~2-5x that of plain Selank) and better CNS delivery. Purported Effects and Mechanisms Based on animal studies, human trials (mostly Russian), and anecdotal reports: Effect Category Details Supporting Evidence Anxiolytic Reduces anxiety without sedation or cognitive impairment. Russian clinical trials (e.g., 2008 study in Zh Nevrol Psikhiatr Im S S Korsakova): 81% efficacy in GAD patients vs. 67% for phenazepam. Acts via GABA modulation and BDNF upregulation. Nootropic/Cognitive Improves memory, learning, focus; neuroprotective. Rodent studies show enhanced hippocampal BDNF and serotonin modulation. Anecdotal: Better than plain Selank for ADHD-like symptoms. Immunomodulatory Boosts IL-6, T-cell activity; anti-viral potential. Tuftsin-like effects; preliminary COVID-19 research in Russia. Other Stress resilience, mood stabilization; minimal side effects. No tolerance/withdrawal in trials; half-life ~10-20 min intranasal. Mechanisms: Upregulates BDNF (brain-derived neurotrophic factor) → neurogenesis. Modulates GABA, serotonin, enkephalins without direct receptor binding. Inhibits enkephalin-degrading enzymes → indirect opioid-like calm. Administration and Dosing (Research Contexts) Forms: Intranasal spray (most common, 200-400 mcg/dose), subcutaneous injection. Typical Protocol (anecdotal/research): Route Dose Frequency Duration Nasal 200-600 mcg 1-3x/day 10-14 days, cycle off 1-2 weeks SubQ 100-300 mcg 1-2x/day Same as above Stacking: Often with Semax (another peptide) for synergy. Pharmacokinetics: Onset: 5-15 min (nasal). Half-life: Extended vs. Selank (exact data sparse; ~minutes to hours). Bioavailability: >80% nasal due to mods. Evidence and Limitations Strengths: Russian RCTs (e.g., 68-patient GAD trial: superior to placebo). Animal data robust for anxiety/neuroprotection. Weaknesses: Limited Western trials; most data from Russia/Eastern Europe. No large Phase III studies. Anecdotes dominate for amidate variant. Safety: Low toxicity in trials (no serious AEs). Rare reports: mild irritation, headaches. Not for pregnant/nursing; consult MD. Availability and Legality Status: Research chemical (not FDA-approved). Sold online as “not for human consumption.” Legal: Unscheduled in US/EU (as of 2024); analogs may fall under peptide regs. Russia: Prescription for Selank. Sources: Vendors like Limitless Biotech, Peptide Sciences (purity varies; test via HPLC/MS). Comparison to Selank: Property Selank N-Acetyl Selank Amidate Stability Moderate High (acetyl amidate) BBB Penetration Good Excellent Potency Baseline 1.5-3x (anecdotal) Cost $30-50/mg $50-80/mg Research Focus Approved drug Experimental nootropic For deeper dives: Check PubMed (“Selank anxiety”), Russian journals, or Examine.com. Always verify purity (3rd-party COAs) if researching. Not medical advice—peptides carry risks.
